Form 8-K RTI SURGICAL, INC. For: Oct 29

Go back to Form 8-K RTI SURGICAL, INC. For: Oct 29

Canaccord Genuity Downgrades RTI Biologics (RTIX) to Hold

October 30, 2015 8:07 AM EDT

Canaccord Genuity downgraded RTI Biologics (NASDAQ: RTIX) from Buy to Hold with a price target of $4.00.

For an analyst ratings summary and ratings history on RTI Biologics click here. For more ratings news on RTI Biologics click here.

Shares of RTI Biologics closed at $4.40 yesterday.

... More

RTI Surgical (RTIX) Reports In-Line Q3 EPS; Trims FY15 Outlook

October 29, 2015 9:09 AM EDT

RTI Surgical (NASDAQ: RTIX) reported Q3 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for the quarter came in at $66.5 million versus the consensus estimate of $69.53 million.

RTI Surgical sees FY2015 EPS of $0.19, versus prior guidance of $0.20-$0.23 and the consensus of... More